title: Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.
abstract: Aggregatibacter actinomycetemcomitans has been described as a member of the indigenous oral microbiota of humans, and is involved in the pathology of periodontitis and various non-oral infections. This bacterium selectively kills human leukocytes through expression of leukotoxin, a large pore-forming protein that belongs to the Repeat in Toxin (RTX) family. The specificity of the toxin is related to its prerequisite for a specific target cell receptor, LFA-1, which is solely expressed on leukocytes. The leukotoxin causes death of different leukocyte populations in a variety of ways. It activates a rapid release of lysosomal enzymes and MMPs from neutrophils and causes apoptosis in lymphocytes. In the monocytes/macrophages, the toxin activates caspase-1, a cysteine proteinase, which causes a proinflammatory response by the activation and secretion of IL-1β and IL-18. A specific clone (JP2) of A. actinomycetemcomitans with enhanced leukotoxin expression significantly correlates to disease onset in infected individuals. Taken together, the mechanisms by which this toxin kills leukocytes are closely related to the pathogenic mechanisms of inflammatory disorders, such as periodontitis. Therapeutic strategies targeting the cellular and molecular inflammatory host response in periodontal diseases might be a future treatment alternative.
authors: Department of Odontology, Umea University, SE-901 87 Umea, Sweden. anders.johansson@odont.umu.se
authors: Anders
authors: A
authors: Johansson
mesh_terms: D016976:Aggregatibacter actinomycetemcomitans / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D016923:Cell Death / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D005098:Exotoxins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism / Q000633:toxicity*; D054884:Host-Pathogen Interactions / Q000276:immunology; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects; D016169:Lymphocyte Function-Associated Antigen-1 / Q000096:biosynthesis / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D009000:Monocytes / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D009504:Neutrophils / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D010518:Periodontitis / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D011485:Protein Binding; D014774:Virulence
chemical_list: D005098:Exotoxins; D016169:Lymphocyte Function-Associated Antigen-1; C018579:leukotoxin